Global Ontogenetic Market Size, Share, Forecast Report, 2020-2027

Ontogenetic is a developmental history of an organism, which includes the study of cognitive, physical, social, and emotional development, which can be attributed to experience with the individuals and the environment within the environment. Ontogenetic is a vast subject and continuous research in the field is expanding its applications. Increasing human and animal population is one of the major factors affecting the market growth, positively. Furthermore, increasing funding for research is one of the major driving factors of the ontogenetic market. Epilepsy is the disorder of a nervous system. According to the last updated report on February 2017 by World Health Organization (WHO), around 50 million people are affected with epilepsy globally, and it affects people of all ages. The report suggests that around 2.4 million people are diagnosed with epilepsy every year globally.

Companies are focusing on merger and also collaborating with universities or academic institutes for further study on ontogenetic. In this regards, in March 2016, Natus Medical Incorporated announced its expansion of neurodiagnostic services into seven new states with the acquisition of the assets of NeuroQuest, LLC. This acquisition helped Natus Medical Incorporated in expanding their network globally and helped to increase the market share. Rapidly changing technology plays an important role in the growth of this market. Technological advancement is opening new doors to the ontogenetic research and use.
Segmentations

The global ontogenetic market is segmented on the basis of devices, application, and end user.

On the basis of the devices, it is segmented into electroencephalography, magnetoencephalography, and others.

On the basis of the application, it is segmented into developmental biology, developmental psychology, developmental cognitive neuroscience, developmental psychobiology, and others.

On the basis of the end user, it is segmented into research laboratories, academic institutes, and others. Furthermore, the research laboratories are segmented into government research laboratories, independent or private research laboratories, and others.
Key Players

Some of key the players in the ontogenetic market are ANT Neuro (the Netherlands), EMS Handels Gesellschaft mbH (Austria), Natus Medical Incorporated (U.S.), Ontogeny, Inc (U.S.), Symbiotic Devices (Australia), and others.